Foster City, CA and Concord, ON (Scicasts) - AB SCIEX has announced its launch as a new company dedicated to life science analytical technologies. According to the announcement, the new company combines the two halves of the highly successful AB SCIEX mass spectrometry joint venture into an integrated organization. AB SCIEX intends to utilize its new operating structure to increase speed to market in developing innovative new solutions and expanding service and support to enable the scientific community to continue its increasing use of mass spectrometry for a broader range of applications.
AB SCIEX provides instrumentation, software and services that are used in a number of critical life science applications, including drug discovery and development, disease studies, and food and environmental safety. Scientists use these technologies, which identify and quantify specific molecules in complex samples, to enhance health and safety. Examples include: improving food safety in China, restoring the Florida Everglades, and discovering biomarkers in France to improve the diagnosis and monitoring of diseases.
Laura Lauman, president of AB SCIEX states, “The vision that led to the creation of AB SCIEX is that this integrated company will be able to shape the future of mass spectrometry in ways far greater than what we have already achieved as the market leader in this industry. By bringing our former joint venture together as a single operating company, AB SCIEX will be able to create a new level of energy, achieve greater customer focus and satisfaction, and further accelerate innovation to keep pace with the dynamic needs of the life science industry.”
